Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-α5 NAM (basmisanil) on intellectual disability associated with Down syndrome.
J Neurodev Disord. 2022 Feb 5;14(1):10. doi: 10.1186/s11689-022-09418-0.
J Neurodev Disord. 2022.
PMID: 35123401
Free PMC article.
Clinical Trial.
Down syndrome as risk factor for respiratory syncytial virus hospitalization: A prospective multicenter epidemiological study.
Sánchez-Luna M, Medrano C, Lirio J; RISK-21 Study Group.
Sánchez-Luna M, et al.
Influenza Other Respir Viruses. 2017 Mar;11(2):157-164. doi: 10.1111/irv.12431. Epub 2016 Dec 30.
Influenza Other Respir Viruses. 2017.
PMID: 27611835
Free PMC article.
Item in Clipboard
Cite
Cite